{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:30:31Z","timestamp":1790508631272,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"AIRC Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117398","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:12:04Z","timestamp":1759536724000},"page":"117398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P4","title":["Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication"],"prefix":"10.1016","volume":"242","author":[{"given":"Alfonso","family":"Zappia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2701-6021","authenticated-orcid":false,"given":"Ilaria","family":"Zanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Parrinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie P.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rusnati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Blesio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Guidetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Scalvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Lodola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-0407","authenticated-orcid":false,"given":"Massimiliano","family":"Tognolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117398_b0005","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.2825356","article-title":"A novel putative tyrosine kinase receptor encoded by the eph gene","volume":"238","author":"Hirai","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117398_b0010","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1038\/s41388-019-0931-2","article-title":"Eph receptor signalling: from catalytic to non-catalytic functions","volume":"38","author":"Liang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117398_b0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41568-023-00634-x","article-title":"Eph receptors and ephrins in cancer progression","volume":"24","author":"Pasquale","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2025.117398_b0020","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1158\/1078-0432.CCR-11-3237","article-title":"Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications","volume":"18","author":"Kirschmann","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117398_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2009.04.009","article-title":"EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt","volume":"16","author":"Miao","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2025.117398_b0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2013.01.007","article-title":"EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme","volume":"23","author":"Day","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2025.117398_b0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12094-012-0786-2","article-title":"Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients","volume":"14","author":"Tu","year":"2012","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bcp.2025.117398_b0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.canlet.2014.12.028","article-title":"Tumor vasculature and glioma stem cells: Contributions to glioma progression","volume":"380","author":"Jhaveri","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2025.117398_b0045","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117398_b0050","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/brain\/awm204","article-title":"for the German Glioma Network, long-term survival with glioblastoma multiforme","volume":"130","author":"Krex","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2025.117398_b0055","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bcp.2012.10.001","article-title":"Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting","volume":"85","author":"Persano","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117398_b0060","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1021\/acs.jmedchem.1c01946","article-title":"Glioblastoma: current status, emerging targets, and recent advances","volume":"65","author":"Thakur","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117398_b0065","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ccr.2012.11.005","article-title":"The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas","volume":"22","author":"Binda","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2025.117398_b0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13046-022-02333-1","article-title":"Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh\/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy","volume":"41","author":"Trivieri","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117398_b0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/onc.2013.590","article-title":"EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties","volume":"34","author":"Miao","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117398_b0080","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1158\/0008-5472.CAN-18-0267","article-title":"Cotargeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma","volume":"78","author":"Qazi","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117398_b0085","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14845","article-title":"EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells","volume":"5","author":"Krusche","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.bcp.2025.117398_b0090","first-page":"22","article-title":"Roles of EphA2 receptor in angiogenesis signaling pathway of glioblastoma multiforme, Malays","volume":"25","author":"Baharuddin","year":"2018","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.bcp.2025.117398_b0095","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/13543776.2024.2402382","article-title":"Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018-present)","volume":"34","author":"Tognolini","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bcp.2025.117398_b0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/ph15020137","article-title":"Protein-protein interaction inhibitors targeting the eph-ephrin system with a focus on amino acid conjugates of bile acids","volume":"15","author":"Guidetti","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bcp.2025.117398_b0105","doi-asserted-by":"crossref","first-page":"24347","DOI":"10.18632\/oncotarget.25272","article-title":"UniPR1331, a small molecule targeting Eph\/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice","volume":"9","author":"Festuccia","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2025.117398_b0110","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41417-021-00379-5","article-title":"Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF\/VEGFR2 in addition to Eph\/ephrin","volume":"29","author":"Rusnati","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bcp.2025.117398_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113067","article-title":"Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice","volume":"180","author":"Ferlenghi","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bcp.2025.117398_b0120","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1021\/acs.jcim.3c01064","article-title":"Molecular determinants of EphA2 and EphB2 antagonism enable the design of ligands with improved selectivity","volume":"63","author":"Guidetti","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bcp.2025.117398_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116681","article-title":"Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line","volume":"276","author":"Guidetti","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117398_b0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1541-7786.MCR-05-0056","article-title":"EphA2 as a novel molecular marker and target in glioblastoma multiforme","volume":"3","author":"Wykosky","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117398_b0135","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/s41467-021-22225-w","article-title":"The white matter is a pro-differentiative niche for glioblastoma","volume":"12","author":"Brooks","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117398_b0140","first-page":"79","article-title":"c-Cbl-dependent EphA2 protein degradation is induced by ligand binding","volume":"1","author":"Walker-Daniels","year":"2002","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2025.117398_b0145","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.2036535100","article-title":"Cancerous stem cells can arise from pediatric brain tumors","volume":"100","author":"Hemmati","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2025.117398_b0150","series-title":"Drug Design and Discovery","first-page":"157","article-title":"Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability","author":"Sylvester","year":"2011"},{"key":"10.1016\/j.bcp.2025.117398_b0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117398_b0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11060-024-04865-2","article-title":"Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials","volume":"171","author":"Motamed-Sanaye","year":"2025","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.bcp.2025.117398_b0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.wneu.2024.10.071","article-title":"Efficacy and safety of bevacizumab combined with temozolomide in the treatment of glioma: a systematic review and meta-analysis of clinical trials","volume":"193","author":"Wang","year":"2025","journal-title":"World Neurosurg."},{"key":"10.1016\/j.bcp.2025.117398_b0170","first-page":"271","article-title":"Cancer stem cells and chemoresistance in glioblastoma multiform: a review article","volume":"10","author":"Safari","year":"2015","journal-title":"J. Stem Cells"},{"key":"10.1016\/j.bcp.2025.117398_b0175","article-title":"Overcoming immune evasion with innovative multi-target approaches for glioblastoma","volume":"16","author":"Su","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117398_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101229","article-title":"Overcoming cancer therapy resistance: from drug innovation to therapeutics","volume":"81","author":"Wei","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2025.117398_b0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature08995","article-title":"Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis","volume":"465","author":"Sawamiphak","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117398_b0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/ijms14010088","article-title":"The role of the VEGF-C\/VEGFRs axis in tumor progression and therapy","volume":"14","author":"Chen","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117398_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5728438","article-title":"Glioma stem cells and their microenvironments: providers of challenging therapeutic targets","volume":"2016","author":"Codrici","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.bcp.2025.117398_b0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10014-017-0284-x","article-title":"Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response","volume":"34","author":"Tamura","year":"2017","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.bcp.2025.117398_b0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2025.117398_b0210","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/sj.bjc.6604676","article-title":"Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer","volume":"99","author":"Chang","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117398_b0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12935-025-03826-7","article-title":"EphrinA2 promotes glioma cell migration and invasion through EphA2 and FAK","volume":"25","author":"Hirai","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2025.117398_b0220","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1038\/onc.2008.328","article-title":"Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor","volume":"27","author":"Wykosky","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117398_b0225","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009403","article-title":"EphA3 CAR T cells are effective against glioblastoma in preclinical models","volume":"12","author":"Martins","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2025.117398_b0230","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41563","article-title":"Ephrin-B3 controls excitatory synapse density through cell-cell competition for EphBs","volume":"8","author":"Henderson","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.117398_b0235","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00384-010-0916-7","article-title":"Loss of cell-surface receptor EphB2 is important for the growth, migration, and invasiveness of a colon cancer cell line","volume":"25","author":"Senior","year":"2010","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.bcp.2025.117398_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111591","article-title":"EphB2 promotes enteric nitrergic hyperinnervation and neurogenic inflammation in DSS-induced chronic colitis in mice","volume":"129","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117398_b0245","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45863","article-title":"Endothelial EphB4 maintains vascular integrity and transport function in adult heart","volume":"8","author":"Lux\u00e1n","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.117398_b0250","doi-asserted-by":"crossref","first-page":"38976","DOI":"10.1038\/srep38976","article-title":"The role of GRIP1 and ephrin B3 in blood pressure control and vascular smooth muscle cell contractility","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500663X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500663X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:36:13Z","timestamp":1773146173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500663X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"alternative-id":["S000629522500663X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117398","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117398"}}